Characterization of Diseases With Salivary Gland Involvement
Background: \- Salivary glands in and around the mouth and throat make saliva. Salivary gland disorders can affect a person s quality of life.
Official registry: https://clinicaltrials.gov/study/NCT02327884 · National Institute of Dental and Craniofacial Research (NIDCR) · enrollment listed as 1,150
What this phase means
This is an observational study. You are not assigned a new experimental drug. Researchers measure what already happens in your care or in daily life.
Phase labels are FDA/ICH categories applied to the registry Phase field. They are not a finding that this study succeeded.
What the registry says happens
This listing is observational (StudyType). The registry does not assign a new experimental drug as the study intervention.
They plan to enroll about 1,150 people at Bethesda. Taking part typically means study visits and measurements plus check-ins.
Official title (unrewritten)
Characterization of Diseases With Salivary Gland Involvement
Primary outcome (registry wording): hypothesis generating
Who it is for (from inclusion criteria)
- Ages 4 Years to 100 Years
- Persons older than 4 years of age, affected with or suspected of being affected with a disease/disorder involving the salivary glands or who is a relative of a person who is affected with these diseases/disorders
- \- Persons 18 years or older with active hepatitis with or without sicca symptoms and patients undergoing immunotherapy with an immune checkpoint inhibitor for oral cancer
- \- Healthy persons age 18 or older, who agree to have blood, urine, saliva or tissue samples collected and studied
Who the registry excludes
- NIH employees who report directly to the principal investigator
- Significant concurrent medical condition or other circumstances that may affect the participant s ability to tolerate or complete the study, such as concurrent chemotherapy or bleeding disorders
- Specific only to the immune checkpoint inhibitor patients, oral cancer as a serious concurrent medical condition, will not serve as an
Public study contact (from the registry)
Eileen M Pelayo
Published on ClinicalTrials.gov. Contact them as a possible participant. They decide eligibility.
Sites listed on ClinicalTrials.gov
1 listed- National Institutes of Health Clinical Center — Bethesda, Maryland (recruiting)
FAQ about this NCT record
Is NCT02327884 still recruiting?
The sponsor posted status “Recruiting” on ClinicalTrials.gov at last ingest. Sites can pause independently. Confirm with the official record and the listed contact.
What phase is NCT02327884?
Not a traditional drug phase. Phase labels are FDA/ICH categories applied to the registry Phase field. They are not a finding that this study succeeded.
Can PlainTrials tell me if I qualify for NCT02327884?
No. The inclusion and exclusion lists on this page are readable extracts of the public eligibility block. Only the study team can screen you.
How to read a ClinicalTrials.gov record · Questions to ask the coordinator · Glossary